Lucie Sancey

Lucie Sancey

ILM-FENNEC UMR 5306, CNRS - Université Lyon 1

Affiliated withCNRS - Université Lyon 1

Research Area

Biography

Lucie Sancey has not added Biography.
If you are Lucie Sancey and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Laser-induced Breakdown Spectroscopy: A New Approach for Nanoparticle's Mapping and Quantification in Organ Tissue
Publication title

Cited by 18

2014

Other Publications

Article
Year
In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.

European journal of nuclear medicine and molecular imaging| PubMed ID: 17674000

2007
2009
2008
Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 19259068

2009
Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 19826406

2010
Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 19826407

2010
In vivo molecular imaging of myocardial angiogenesis using the alpha(v)beta3 integrin-targeted tracer 99mTc-RAFT-RGD.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology| PubMed ID: 20087797

2010
2010
Targeted delivery of a proapoptotic peptide to tumors in vivo.

Journal of drug targeting| PubMed ID: 21182462

2011
2011
The multiple roles of amphiregulin in human cancer.

Biochimica et biophysica acta| PubMed ID: 21658434

2011
2012
Ultrasmall rigid particles as multimodal probes for medical applications.

Angewandte Chemie (International ed. in English)| PubMed ID: 22057640

2011
2012
2012
2013
2013
2013
2013
2013
2013
2013
2013
2014